Acceleration Grants in Cancer Research

0 Saves · 0 Shares · 1 Comments Discussion

Grant Name

Funder

Israel Cancer Research Fund (ICRF)

Country or Region

United States

Research Field

Cancer Biology

Cancer or Carcinogenesis

Oncology

Deadline

December 1, 2021 (Expired)

Grant Size

Upper $140,000USD Lower $70,000USD Awarded grants will be for a period of two (2) years, with a funding level of $70,000 per year. Funding for the second year is contingent upon progress in the preceding funding period, as documented in a progress report due on June 30.

Contact Info

ellen.rubin@icrfny.org

Eligibility

ICRF Acceleration Grants are intended to support the research of established investigators. The grant is made to an institution with the understanding that it will support a specific project under the direction of a designated principal investigator. To apply for an ICRFfunded grant, an investigator must be a citizen of Israel (proof of Israeli citizenship must be furnished upon request). Typically, all research must be conducted in Israel. However, in the case of certain collaborative grants, joint applications are considered from co-investigators, only one of whom is an Israeli citizen proposing research that will be conducted at an Israeli institution. A single investigator may not hold two ICRF grants concurrently. If you are currently the recipient of ICRF funding, you may only apply for another ICRF grant, if the start date for the new application falls after the termination date for current funding.

Description

The Acceleration Grants are intended to speed up our understanding of the biology underlying cancer and to provide new knowledge that will rapidly enhance the development of innovative therapeutics. Grant applications responding to this call must propose highly-innovative approaches that have the promise of pioneering new ways of thinking about cancer biology and therapeutics. Preliminary data are not a prerequisite, but applicants are encouraged to provide data from disparate sources to support the rationale upon which the new concepts are derived. While not a requirement, grants that utilize interdisciplinary approaches and that are multi-investigator are encouraged. Of paramount importance, however, is the novelty of the approach and the promise of accelerating progress to a complete mechanistic understanding of cancer, its management and its cure. Eligibility ICRF Acceleration Grants are intended to support the research of established investigators. The grant is made to an institution with the understanding that it will support a specific project under the direction of a designated principal investigator. To apply for an ICRFfunded grant, an investigator must be a citizen of Israel (proof of Israeli citizenship must be furnished upon request). Typically, all research must be conducted in Israel. However, in the case of certain collaborative grants, joint applications are considered from co-investigators, only one of whom is an Israeli citizen proposing research that will be conducted at an Israeli institution. A single investigator may not hold two ICRF grants concurrently. If you are currently the recipient of ICRF funding, you may only apply for another ICRF grant, if the start date for the new application falls after the termination date for current funding.

Website

https://www.icrfonline.org/apply-for-a-grant/#acceleration

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link